Health Tech Conference 2022 - Friday 9th December 2022
Latest Health Tech Event Manchester Updates by HNC Healthcare News Channel.
Health Tech Conference 2022
DATE:Friday 9th December 2022
TIME:10:00 AM - 02:30 PM
LOCATION:No. 1 Circle Square, Oxford Road, , M1 7ED
COST:£60 live ticket (member) / £75 live ticket (non-member) / £30 virtual ticket (member) / £50 virtual ticket (non-member)
CATEGORIES: - Business Booster - Healthcare - Innovation - Key Events - SME Club Innovation in Healthcare is crucial in order to meet changing demands and deliver better outcomes for patients. Manchester is home to world-leading research and development assets as well as the largest clinical academic campus in Europe and continues to be at the forefront of innovative healthcare treatments.
Our Health Tech Conference is now in its 3rd year and has established itself as an essential, must attend event in the Healthcare calendar. We will explore what new and innovative ideas have been developed in the past 12 months and what kind of a difference are they going to make to the future of healthcare delivery in the UK. We will be looking at the changes in legislation, operating methods and culture and how all these things are driving a fundamental shift in our healthcare system for good.
We are delighted to be able to offer NHS employees free tickets to this event - just book on using your NHS email address.
About the Speakers: Paul Dennett
Lord Mayor - Salford City Council
Paul was born in Warrington, later moving to Salford during his post-graduate studies time at University, qualifying with a BA (Hons) in International Business, an MSc in Human Resource Management and Industrial Relations and MRES in Research in Social Sciences. Paul worked as a lecturer and an active Trade Unionist before being elected as a local councillor for Langworthy in 2012 and held the Strategic Assistant Mayor position at Salford City Council, responsible for workforce, industrial relations, equalities, social value and impact until becoming the Elected Mayor in 2016.
Paul has a long history of campaigning on social issues and since becoming the City Mayor has campaigned on equalities, financial inclusion, the real living wage – with Salford becoming the first accredited Living Wage Council in Greater Manchester. Similarly, Paul’s more recent work has focused on social value, anti-poverty, delivering an inclusive economy and critically tackling the housing and homelessness crisis.
Paul is currently the Greater Manchester Combined Authority’s (GMCA) Deputy Mayor and his GMCA portfolio covers spatial planning, homelessness and more recently extending to Healthy Lives & Quality Care. Paul is the joint-Chair(s) of Greater Manchester’s Integrated Care Partnership and Joint Partnership Delivery Committee and Deputy Chair of the new Integrated Care Board.
Paul’s previous GMCA portfolios included leading on Low carbon, Waste and Environment and then the Housing and Infrastructure – overseeing the development of the Greater Manchester Housing Strategy and leading on Greater Manchester’s Plan for Homes, Jobs & the Environment. Paul has also led the work on the Infrastructure Framework 2040 which will provide the focus for the Greater Manchester Infrastructure Strategy. Jess Jackson
Jess Jackson is an investment manager at Praetura Ventures and is responsible for identifying and managing investment opportunities for our EIS Growth Fund and the GMC Life Sciences Fund By Praetura. Jess boasts a wealth of experience working with startups across multiple sectors, including businesses with a social impact focus and is a well-known figure in the North’s investment scene. She is a founding member of Fund Her North – a collective which champions investment opportunities for women – and regularly gives talks around this subject and the early-stage investment market. Prior to joining Praetura Ventures, Jess managed fund deployment at GC Angels and HNWI Capital. Rory Cameron
CEO & Co-Founder - Gendius
Rory Cameron is CEO and Co-Founder at Gendius, a health data and insights business focussed on metabolic disease. After a successful career in Pharmaceuticals at AstraZeneca, Genzyme and InterMune. Rory set up Gendius to help people with diabetes live a better life with a particular focus on the prevention of complications of diabetes. Gendius have two commercial offerings to do this; intellin their remote management platform for the management of diabetes and their CKD prioritizer (a pre-screening algorithm to identify those at highest risk of having Chronic Kidney Disease). These products have been validated in 28 countries and in data sets of over 140,000 patients and 30 million data points. Gendius are based in the North West with the data science team all with PhDs from The University of Manchester, with whom they have various academic partnerships. Dr Janine Swarbrick
Janine is a Senior Patent Attorney at HGF Limited, one of Europe’s leading Intellectual Property (IP) firms. She is based in the Electronics and Computing group, and has over a decade of experience of helping inventors from SMEs, universities, and multinational companies, to protect their inventions relating to various technologies in physics and computing. Day to day she drafts and prosecutes patent applications, and enjoys working with clients who are developing their IP strategies by getting to know their business and work with them to ensure their IP provides the maximum value for their business and helps them to achieve their business goals.
She works across a broad range of technologies including MedTech, telecommunications, nanotechnology, electronic systems, automotive technologies, and software. She is co-lead of HGF’s Electronics MedTech group focussing on supporting innovators to protect their ideas in MedTech and healthcare technologies. MedTech innovation is currently developing at a rapid rate, which provides Janine with an enjoyable, fascinating and diverse range of cases for her to get her teeth into support those working in the very latest cutting edge developments in this field.
She is also passionate in helping and educating others about science, innovation, and opportunities in the IP profession, and is involved in school outreach projects helping to enthuse and inspire confidence in the next generation of young scientists. She is also a member of the HGF DEI focus group, working towards improving equality, diversity and inclusion for everyone working in IP.” Dave Foreman
David Foreman is the MD and founder of Praetura Ventures, an award-winning tech and life sciences focused VC, born-and-bred in the North of England. Praised for its early backing of northern success stories such as Peak, Reacta, XR Games and Culture Shift, the Manchester-based VC has now become known for its ‘more than money’ approach to supporting early-stage founders post investment. Praetura’s portfolio companies benefit from active mentorship from the company’s operational partners, who are industry-heavyweights that have led businesses such as AO, ANS, Apple, Co-op Bank, Dr Martens, Social Chain, OSTC and MPP Global.
As the largest partner on the British Business Investment’s Regional Angels Programme, Praetura’s team are focused on backing northern-based businesses with global potential. Having raised over £125m since 2019, the team typically looks to invest £1-3m in tech and life sciences businesses through their EIS Growth fund and £50k-2m through the GMC Life Sciences Fund By Praetura, which includes partners Bruntwood SciTech, Greater Manchester Combined Authority and Cheshire & Warrington LEP.
Interested In The Event?
If you’re interested in attending, you can book online here.